The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Merck & Co Inc

NYSE: MRK
Last

(U.S.) $63.07

Today's change+0.34 +0.53%
Updated August 25 11:49 AM EDT. Delayed by at least 15 minutes.
 

Merck & Co Inc

NYSE: MRK
Last

(U.S.) $63.07

Today's change+0.34 +0.53%
Updated August 25 11:49 AM EDT. Delayed by at least 15 minutes.

Merck & Co Inc up (U.S.)$0.34

Merck & Co Inc is up today by (U.S.)$0.34 or 0.53% to (U.S.)$63.07. Shares have lost 0.89% over the last five days, but sit 1.46% below their 52-week high. This security has outperformed the S&P 500 by 6.66% during the last year.

Key company metrics

  • Open(U.S.) $62.86
  • Previous close(U.S.) $62.73
  • High(U.S.) $63.07
  • Low(U.S.) $62.49
  • Bid / Ask(U.S.) $63.06 / (U.S.) $63.07
  • YTD % change+19.40%
  • Volume2,066,514
  • Average volume (10-day)7,234,606
  • Average volume (1-month)10,436,772
  • Average volume (3-month)9,457,789
  • 52-week range(U.S.) $47.97 to (U.S.) $64.00
  • Beta0.65
  • Trailing P/E34.54×
  • P/E 1 year forward16.75×
  • Forward PEG2.66×
  • Indicated annual dividend(U.S.) $1.84
  • Dividend yield2.92%
  • Trailing EPS(U.S.) $1.83
Updated August 25 11:49 AM EDT. Delayed by at least 15 minutes.
S&P TSX0.23%Sector:HealthcareIndustry:Pharmaceuticals - Diversified
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q2/2016Q1/2016Q4/2015Q3/2015
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedJun 30, 201606/30/2016Mar 31, 201603/31/2016Dec 31, 201512/31/2015Sep 30, 201509/30/2015
Revenue9,8449,31210,21510,073
Total other revenue--------
Total revenue9,8449,31210,21510,073
Gross profit6,3325,7876,4466,382
Total cost of revenue3,5123,5253,7693,691
Total operating expense8,3217,6408,4967,846
Selling / general / administrative2,3532,3132,5602,429
Research & development2,0871,6041,7801,483
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)369198387243
Other operating expenses, total--------
Operating income1,5231,6721,7192,227
Interest income (expense), net non-operating-171-172-169-165
Gain (loss) on sale of assets--------
Other--------
Income before tax1,5041,6248162,397
Income after tax1,2091,1309821,831
Income tax, total295494-166566
Net income1,2051,1259771,826
Total adjustments to net income--------
Net income before extra. items1,2051,1259771,826
Minority interest-4-5-5-5
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items1,2051,1259771,826
Inc. avail. to common incl. extra. items1,2051,1259771,826
Diluted net income1,2051,1259771,826
Dilution adjustment--------
Diluted weighted average shares2,7892,7952,8142,836
Diluted EPS excluding extraordinary itemsvalue per share0.430.400.350.64
Dividends per sharevalue per share0.460.460.460.45
Diluted normalized EPSvalue per share0.540.450.440.71